SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-017826
Filing Date
2024-06-21
Accepted
2024-06-21 16:15:21
Documents
1
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 form4-06212024_040616.html 4  
1 form4-06212024_040616.xml 4 4049
  Complete submission text file 0001415889-24-017826.txt   5536
Mailing Address INSPIRE PHARMACEUTICALS, INC., 4222 EMPEROR BLVD., STE. 470 DURHAM NC 27703-8466
Business Address
YERXA BENJAMIN R (Reporting) CIK: 0001145910 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37783 | Film No.: 241060354

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)